Skip to Main Content

Author Details

Jung Gil Park
Yeungnam University Hospital
2006
61
16
PMIDPaper TitleJournal TitlePublished Year
37831433New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey's discriminant function <32.Hepatol Int2024
36914242Performance of Simple Fibrosis Score in Non-Alcoholic Fatty Liver Disease with and without Type 2 Diabetes.Endocrinol Metab (Seoul)2023
37895312Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma.Genes (Basel)2023
37449430Unraveling Metabolic Dysfunction-Associated Fatty Liver Disease: Refining Sub-Phenotypes for Resolving Its Heterogeneity.Gut Liver2023
36977156Clinical Implications for the Comprehensive Interpretation of Radiologic and Immunodiagnostic Tests in Patients Suspected of Parasitic Hepatic Cyst, a Rare Case in Korea.Trop Med Infect Dis2023
37069419Impact of metabolic factors on risk of cardiovascular disease in nondiabetic metabolic dysfunction-associated fatty liver disease.Hepatol Int2023
35054267Deep Learning-Based Four-Region Lung Segmentation in Chest Radiography for COVID-19 Diagnosis.Diagnostics (Basel)2022
35566588Platelet-to-White Blood Cell Ratio Is Associated with Adverse Outcomes in Cirrhotic Patients with Acute Deterioration.J Clin Med2022
36140656Prognostic Impact of Myosteatosis on Mortality in Hospitalized Patients with COVID-19.Diagnostics (Basel)2022
35867702Effect of switching from nucleos(t)ide maintenance therapy to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomized trial.PLoS One2022
36011395Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma.Genes (Basel)2022
32856240Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.Dig Dis Sci2021
33879706Long interspersed nuclear element-1 hypomethylation is associated with poor outcomes via the activation of ST18 in human hepatocellular carcinoma.Medicine (Baltimore)2021
33764550Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther2021
33711739Deep metric learning-based image retrieval system for chest radiograph and its clinical applications in COVID-19.Med Image Anal2021
33846041A multi-center study of COVID-19 patient prognosis using deep learning-based CT image analysis and electronic health records.Eur J Radiol2021
33782216Multicenter Analysis of Clinical Features and Prognosis of COVID-19 Patients with Hepatic Impairment.Gut Liver2021
34526699Federated learning for predicting clinical outcomes in patients with COVID-19.Nat Med2021
34068776Low Skeletal Muscle Mass Is a Risk Factor for Subclinical Atherosclerosis in Patients with Nonalcoholic Fatty Liver Disease.Diagnostics (Basel)2021
33961702Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated? Authors' reply.Aliment Pharmacol Ther2021
34207587Association of Skeletal Muscle and Adipose Tissue Distribution with Histologic Severity of Non-Alcoholic Fatty Liver.Diagnostics (Basel)2021
34170539Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply.Aliment Pharmacol Ther2021
34166456Diagnostic usefulness of the spot urine sodium/potassium ratio in cirrhotic patients with ascites.PLoS One2021
33442676Federated Learning used for predicting outcomes in SARS-COV-2 patients.Res Sq2021
33381930Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma.Yonsei Med J2021
32429077Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.Nutrients2020
33053932Clinical outcomes of coronavirus disease 2019 in patients with pre-existing liver diseases: A multicenter study in South Korea.Clin Mol Hepatol2020
33184086Fibrosis-4 index as a predictor for mortality in hospitalised patients with COVID-19: a retrospective multicentre cohort study.BMJ Open2020
33044938Severity and Consolidation Quantification of COVID-19 From CT Images Using Deep Learning Based on Hybrid Weak Labels.IEEE J Biomed Health Inform2020
32975060Association between Atrial Fibrillation and Advanced Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease.Yonsei Med J2020
32872734Clinical characteristics of coronavirus disease 2019 patients with diarrhea in Daegu.Korean J Intern Med2020
33022942Plasma Long Noncoding RNA <i>LeXis</i> is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis.Life (Basel)2020
32413995Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.Genes (Basel)2020
32204580Anti-nuclear antibody-negative immunoglobulin G4-associated autoimmune hepatitis mimicking lymphoproliferative disorders.Yeungnam Univ J Med2020
32135539Sarcopenia Is a New Risk Factor of Nonalcoholic Fatty Liver Disease in Patients with Inflammatory Bowel Disease.Dig Dis2020
29792020Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world.Korean J Intern Med2019
30732129Liver fibrosis is associated with risk for colorectal adenoma in patients with nonalcoholic fatty liver disease.Medicine (Baltimore)2019
30338850Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.Int J Cancer2019
30667551Association of low skeletal muscle mass with advanced liver fibrosis in patients with non-alcoholic fatty liver disease.J Gastroenterol Hepatol2019
29089265Tenofovir, entecavir, and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B.Dig Liver Dis2018
30191729Clinical significance of microRNA-21 expression in disease progression of patients with hepatocellular carcinoma.Biomark Med2018
29703062Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article.Medicine (Baltimore)2018
29625906Tenofovir disoproxil fumarate-induced severe liver injury in a patient with chronic hepatitis B virus infection.Dig Liver Dis2018
29794814Comparison of acoustic radiation force impulse elastography and transient elastography for prediction of hepatocellular carcinoma recurrence after radiofrequency ablation.Eur J Gastroenterol Hepatol2018
29320775Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.Med Princ Pract2018
28614215Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.Medicine (Baltimore)2017
28364952Early complications after percutaneous radiofrequency ablation for hepatocellular carcinoma: an analysis of 1,843 ablations in 1,211 patients in a single centre: experience over 10 years.Clin Radiol2017
29108251Clinical significance of lncRNA-ATB expression in human hepatocellular carcinoma.Oncotarget2017
29085491Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report.Oncol Lett2017
25220468Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension.Hepatology2015
  • 1 - 50 of 61

Recommended Authors

University of Nebraska Medical Center
Career Start Year 2014
Number of shared co-authors 0
Shulan International Medical College, Zhejiang Shuren University
Career Start Year 2012
Number of shared co-authors 0
Western University
Career Start Year 2011
Number of shared co-authors 0
Hubei University of Chinese Medicine
Career Start Year 2011
Number of shared co-authors 0
The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University
Career Start Year 2010
Number of shared co-authors 0
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 0
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 0
King Faisal Specialist Hospital & Research Centre
Career Start Year 2007
Number of shared co-authors 0
Mie University Graduate School of Medicine
Career Start Year 2005
Number of shared co-authors 0
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 0
Cumming School of Medicine
Career Start Year 2004
Number of shared co-authors 1
Humanitas University
Career Start Year 2003
Number of shared co-authors 0
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Charite-Universitatsmedizin Berlin
Career Start Year 1999
Number of shared co-authors 0
College of Medicine, University of Florida
Career Start Year 1999
Number of shared co-authors 0
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 1997
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 0
University of California San Diego
Career Start Year 1997
Number of shared co-authors 1
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 2
Cliniques Universitaires Saint-Luc (CUSL)
Career Start Year 1996
Number of shared co-authors 0
Ajou University School of Medicine
Career Start Year 1994
Number of shared co-authors 5
University of Queensland
Career Start Year 1993
Number of shared co-authors 0
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 0
University of Washington
Career Start Year 1989
Number of shared co-authors 0
Virginia Commonwealth University
Career Start Year 1989
Number of shared co-authors 0
Mie University
Career Start Year 1988
Number of shared co-authors 0
Pinnacle Clinical Research Center
Career Start Year 1983
Number of shared co-authors 1
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 0

Collaborators

Kyungpook National University
Co-authored papers 33
Kyungpook National University
Co-authored papers 32
Kyungpook National University
Co-authored papers 27
Yeungnam University College of Medicine
Co-authored papers 25
Keimyung University School of Medicine
Co-authored papers 11
Yonsei University College of Medicine, Severance Hospital
Co-authored papers 11
Catholic University of Daegu School of Medicine
Co-authored papers 10
Massachusetts General Hospital
Co-authored papers 6
Massachusetts General Hospital
Co-authored papers 6
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 5
Co-authored papers 4
Massachusetts General Hospital
Co-authored papers 4
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 4
Massachusetts General Hospital, Harvard University
Co-authored papers 3
University of California Davis
Co-authored papers 3
Mount Sinai Health System and University Health Network
Co-authored papers 2
Kashan University of Medical Sciences, Iran Trauma Research Center
Co-authored papers 2
Hasso Plattner Institute for Digital Health, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Technical University of Munich (TUM)
Co-authored papers 2
National Cancer Institute, National Institutes of Health
Co-authored papers 2
Lunenfeld-Tanenbaum Research Institute
Co-authored papers 2
University of California san francisco
Co-authored papers 2
Self-Defense Forces Central Hospital
Co-authored papers 2
Universita del Piemonte Orientale
Co-authored papers 2
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 2
Iran University of Medical Sciences
Co-authored papers 2
University of California san francisco
Co-authored papers 2
University of California
Co-authored papers 2
Medical Review and Pharmaceutical Benefits Division
Co-authored papers 2
Harvard T.H. Chan School of Public Health
Co-authored papers 2